Literature DB >> 27935413

Stable core virome despite variable microbiome after fecal transfer.

Felix Broecker1,2,3, Giancarlo Russo4, Jochen Klumpp5, Karin Moelling1,2.   

Abstract

We recently described the 4.5-year time course of the enteric bacterial microbiota and virome of a patient cured from recurrent Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT). Here, we extended the virome analyses and found the patient's phage population to exhibit highly donor-similar characteristics following FMT, which remained stable for the whole period tested (up to 7 months). Moreover, the detected viral populations of donor and patient exhibited comparable diversity and richness. These findings were unexpected since enteric viromes are normally highly variable, assumed to influence the bacterial host community and change with environmental conditions. In contrast to the virome, the bacterial microbiota varied indeed for more than 7 months with ongoing dysbiosis before it reached donor similarity. Our findings that are based on sequence information and protein domain analysis seem to suggest that stable phage properties correlate with successful FMT better than the changing bacterial communities. We speculate that we here preferentially detected a stable core virome, which dominated over a variable flexible virome that may have been too heterogeneous for experimental detection or was underrepresented in the databases. It will be interesting to analyze whether the enteric virome allows predictions for the clinical outcome of FMT for rCDI and other diseases such as inflammatory bowel disease or obesity.

Entities:  

Keywords:  Clostridium difficile; core virome; fecal microbiota transplantation; long-term analysis; microbiome; sequencing; virome

Mesh:

Substances:

Year:  2016        PMID: 27935413      PMCID: PMC5479397          DOI: 10.1080/19490976.2016.1265196

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


Introduction

FMT is an effective treatment against recurrent C. difficile infection (rCDI) that may soon be applied to other dysbiotic gastrointestinal conditions including inflammatory bowel disease (IBD) and obesity. FMT-mediated cure of rCDI is associated with expanded beneficial Bacteroidetes and Firmicutes bacteria in the patient's intestine, whereas detrimental Proteobacteria populations contract. The 1014 gut bacteria per individual are conventionally considered the most relevant component of FMT. In contrast, the 10 times more numerous enteric viruses have remained largely unexplored in this context. The human gut virome is mainly composed of bacteriophages belonging to the Caudovirales order, which are tailed double-stranded (dsDNA) phages, and the ssDNA Microviridae family but also harbors a diverse community of eukaryotic viruses and probably giant viruses such as Chlorella viruses with a poorly understood impact on health and disease. We have recently reported on a patient with antibiotic-refractory rCDI – termed the “Zurich patient” – who experienced immediate subjective improvement and clinical cure within 2 weeks following FMT after about 7 months of C. difficile-induced disease. To characterize enteric bacterial and viral communities over time, we have subjected total dsDNA isolated from patient and donor feces sampled up to 4.5 y post-FMT to 16S rRNA gene or metagenomic sequencing analyses, respectively (Fig. 1a). An overview of the respective sequencing yields is shown in Tables S1 and S2. Despite immediate clinical cure within days, the patient's bacterial microbiota remained dysbiotic during the time period tested up to 7 months post-FMT and were characterized by expanded Proteobacteria, a hallmark of gut inflammation (Fig. 1b). Prolonged dysbiosis was an unusual characteristic of this case report, as the majority of rCDI patients have been reported to attain highly donor-similar bacterial communities within days or weeks following successful FMT. Only after a longer period up to 4.5 years, bacterial communities have reached a highly donor-similar composition in the Zurich patient. We have previously characterized the fecal dsDNA viromes of donor and patient by querying open reading frames (ORFs) predicted from metagenomic contigs against the non-redundant protein (NRPROT) database using BLASTP. Thereby, we have identified about 20 Caudovirales phage species among all samples studied. This approach, however, only captured a very small fraction of the actual phage population, since ORFs of prophages (phages integrated within bacterial genomes) were frequently taxonomically assigned to the respective host bacterium (unpublished observation) and viral sequences are notoriously underrepresented in current sequence databases including NRPROT. Therefore, the results presented here are based on the rather small number of available phage sequences.
Figure 1.

(a) Timeline of fecal samples of donor (D0 and D4) and patient (P1 through P4) subjected to 16S rRNA gene sequencing (all samples) or metagenomic sequencing (samples D0 and P1-P3). (b) Relative abundances of bacterial phyla as inferred by 16S rRNA gene sequencing. (c) and (d) Relative proportions of bacterial phylum-specific (c) or phage-specific (d) Pfam domains identified from metagenomic ORFs. (e) Relative abundances of phage families identified by aligning phage-specific ORFs against tailed phage protein sequences of the NRPROT database. (f) Virus family-specific relative proportions of phage-specific Pfam domains identified from metagenomic ORFs.

(a) Timeline of fecal samples of donor (D0 and D4) and patient (P1 through P4) subjected to 16S rRNA gene sequencing (all samples) or metagenomic sequencing (samples D0 and P1-P3). (b) Relative abundances of bacterial phyla as inferred by 16S rRNA gene sequencing. (c) and (d) Relative proportions of bacterial phylum-specific (c) or phage-specific (d) Pfam domains identified from metagenomic ORFs. (e) Relative abundances of phage families identified by aligning phage-specific ORFs against tailed phage protein sequences of the NRPROT database. (f) Virus family-specific relative proportions of phage-specific Pfam domains identified from metagenomic ORFs.

Results

To reveal the most abundant phage species within the fecal samples, we queried the metagenomic contigs against virus sequences deposited in the nucleotide collection of NCBI using BLASTN. About 0.04% of all contigs aligned to known viruses with sequence identity >80% (Table S2). We solely found Caudovirales phages stratifying into Myo-, Podo- and Siphoviridae families. The identification of strictly lytic viruses such as T4-like phages (Myoviridae), which do not form prophages, confirmed that the sequencing approach also captured free phages (Table S3). Not surprising, of the 26 phages identified among all samples, 22 had Enterobacteriaceae genera such Escherichia, Cronobacter, Citrobacter, Shigella and Salmonella as their hosts. Cronobacter phage vB CsaM_GAP161 was identified in both donor and patient (samples D0 and P2) and may have been transmitted during FMT. However, there were no overlapping contigs to confirm the sequence identity between samples of donor and patient. For a more comprehensive characterization of enteric phages and to study their possible transmission during FMT, we re-analyzed the ORF sets of patient and donor described above using the Pfam protein families database of conserved protein domains and the UproC program. Of all ORFs, 64% contained recognizable Pfam motifs, 99.9% of which were taxonomically assigned to bacteria, a taxon that also includes phages in this database (Table S3). In accordance with the 16S data, Bacteroidetes-specific protein clusters were less abundant in the patient than in the donor, while those specific for Proteobacteria were expanded in the patient (Fig. 1c). About 2% of all Pfam domains were assigned to essential bacteriophage functions, as identified using a list of Pfam families described previously (Fig. 1d). The composition of phage-specific protein clusters was highly donor-similar in the patient and stable over time. In order to determine the taxonomic distribution of these phage-specific domains, the corresponding ORFs were aligned to tailed phages protein sequences of NRPROT using BLASTP (Fig. 1e). As expected, almost all of the phage-specific ORFs, 3,643 of 3,467, aligned to sequences of tailed phages (Table S4) that represent 96% of all known phages. For each ORF, the BLASTP hit with the lowest e-value was used for taxonomic assignment at the viral family level. In all samples of donor and patient, Siphoviridae were most abundant, followed by Myoviridae and Podoviridae, all 3 families belonging to the tailed Caudovirales order. Each identified viral family showed a distinct distribution of phage-specific Pfam domains (Fig. 1f). To further compare phage populations among the different samples, we calculated their α diversity (Shannon's H’) and richness (Menhinick's D). The diversity and richness measures calculated from taxonomic assignment of NRPROT were highly similar among phage populations when all tailed phages were taken into account (Fig. 2a), whereby Shannon's H’ ranged between 4.83 (P1) and 5.06 (P3) and Menhinick's D between 9.11 (P3) and 9.32 (P1). The most diverse and rich subpopulations were the Siphoviridae, followed by Myoviridae, Podoviridae, unclassified Caudovirales and unclassified phages. All subpopulations exhibited comparable diversity and richness among samples. Similar trends were observed when diversity and richness were calculated from Pfam domains (Fig. 2b), whereby differences among samples in the least diverse subpopulations, unclassified Caudovirales and unclassified phages, were more pronounced. This was likely due to the relatively low numbers of Pfam identifiers (between 3 to 8 per sample, see Table S5) assigned to these subpopulations that resulted in less robust measures for H’ and D. The overall findings showed that, surprisingly, despite dysbiotic bacterial microbiota for at least 7 months post-FMT, phage populations in the same time period were highly donor-similar and stable in composition, diversity and richness.
Figure 2.

α diversity (Shannon's H’) and richness (Menhinick's D) measurements based on phage species taxonomically assigned by NRPROT (a) and on Pfam domain annotation (b). Sample identifiers D0 and P1-P3 are explained in Fig. 1a.

α diversity (Shannon's H’) and richness (Menhinick's D) measurements based on phage species taxonomically assigned by NRPROT (a) and on Pfam domain annotation (b). Sample identifiers D0 and P1-P3 are explained in Fig. 1a.

Discussion

Phage communities of the herein described patient were unexpectedly similar to the donor in composition (Fig. 1e, f), diversity and richness (Fig. 2) and stable even when bacterial microbiota were dysbiotic and variable. This is especially surprising since the enteric virome, as determined by sequencing of isolated virus-like particle (VLP) derived DNA, is known to be variable individually over time and, more substantially so, between individuals. Our findings suggest that a predominant fraction of enteric phages was transferred from donor to the patient during FMT and then remained donor-like and stable. The approach described here sought to overcome several challenges encountered during virome analysis. Due to their low abundance in feces, viral genomes are usually enriched by removing bacteria through centrifugation and filtration followed by VLP isolation with cesium chloride density gradients. Efficient virome sequencing then requires promiscuous amplification of viral genomes, for instance, with the phi29 polymerase. Assignment of the generated reads to virus species remains incomplete since the majority of sequences have no homologues in the current viral nucleotide databases. Therefore, the reference databases need to be expanded to allow for more comprehensive virome analyses in the future. The extensive sequence diversity found in the virosphere requires innovative means of virus sequence discovery. Novel phages have recently been identified by assembling reads from different metagenomic samples (cross-assembly) that overcomes the low abundance of phage sequences within single metagenomes, or by searching metagenomes for virus-specific sequence signatures such as oligonucleotide repeats. The discovery of new viral species may also benefit from improvements of sequencing technology with respect to sequencing depth, read length and accuracy that facilitate the identification of low abundance microbial taxa such as viruses. These advancements may also improve the quality of viromes inferred from total metagenomes. Here, we tackled the aforementioned experimental and technical difficulties by identifying viral protein domains from total dsDNA metagenomes. The metagenomes of the patient exhibited an expansion of Proteobacteria and a depletion of Bacteroidetes as observed by Pfam domain analysis (Fig. 1c). Thus, although taxa with larger genomes may be overrepresented in the dsDNA metagenomes, they at least partially reflected the dysbiosis of the patient observed by 16S rRNA gene sequencing (Fig. 1b). The analysis of viromes through querying ORFs predicted from metagenomic contigs in the NRPROT and Pfam databases allowed for a more comprehensive characterization of phage communities than direct contig alignment against the NCBI nucleotide database that only yielded 3–14 identified viral species per sample (Table S3). Since we used total dsDNA to identify viral sequences, the herein described phage populations represent both free phages and prophages that were indistinguishable by our approach. Also, the number and type of isolated phage genetic material depends on the isolation method, which was adjusted for bacterial DNA and might have excluded some phage populations. Another limitation of this study is that the patient sample before FMT was missing. However, it can be assumed that the patient's microbiota at that time was severely dysbiotic due to month-long antibiotic therapy prior to FMT. It has been shown previously that antibiotic treatment against rCDI leads to an expansion of Proteobacteria and a depletion of Bacteroidetes and Firmicutes, characteristics that were partially observed in the patient after FMT as well (Figs. 1b, c). To what extent the virome is altered during rCDI remains to be shown. Future studies with more FMT-treated patients are needed to confirm the transmissibility of phage populations observed in this case report. Compared to healthy adults, the enteric virome/microbiome of IBD patients has been described to harbor increased numbers of unintegrated phages and reduced bacterial diversity as disease indicators. In the case reported here, the patient, due to month-long repeated antibiotic treatment, was likely deprived from most of the endogenous gut microbiota that was replenished by the donor's. In a healthy microbiome/virome, phages are less abundant than during inflammatory diseases and predominantly exist as integrated prophages. Since our sequencing approach included both free phages and prophages that we could not distinguish, DNA sequence information specifically from isolated VLPs will be required to reveal whether free phage communities likewise exhibit donor similarity and stability following FMT as observed here. It is known that enteric phages normally influence the complexity of the host community. The bacteria in the case described here indeed exhibited heterogeneity and variability, which stood in stark contrast to the phage community. We consider the possibility that a dominating subpopulation of phages and/or a selection of genetic information and protein domains with lower complexity was preferentially detected here. The hypothesis of a dominating phage subpopulation is supported by studies of the ocean microbiome by the Tara Oceans expedition in which viral community patterns were analyzed with respect to protein clusters and the DNA sequence space that is unknown by up to 93%. Viral protein cluster analysis revealed the existence of a relatively small “core virome” shared among samples that is present in a global “pan virome” whose richness is several logs bigger. According to the recently described seed-bank hypothesis, the diversity of viral populations at different sites in the ocean is generated by incorporating viruses of the pan virome moving between environments through ocean currents. Local adaptation and diversification then occurs due to environmental constraints. Thus, we hypothesize that we here detected the transmission and acceptance of a predominant core fecal virome of limited complexity, as described for marine samples, in which highly diverse sequences of low abundancy seem to be undetectable. This phenomenon may also apply here for fecal samples. Furthermore, exchange of viruses between individuals by FMT may correspond to the described dispersal of marine viruses by ocean currents. Individual fecal virome diversity may result from local adaptation of the core virome to the host's intestinal environment. We speculate that in the case described here the core virome was detected, whereby more variable virus populations probably present in the feces were either too low in abundance or not distinguishable from the core with respect to protein domains. Detection of viral variants arising from recombination events, horizontal gene transfer or single nucleotide mutations would require more comprehensive sequencing of VLP-enriched DNA, as described. Thus, the gut ecosystem may resemble the marine ecosystem and the analysis of both systems may support each other. In line with our findings, it was recently shown – at the DNA level – that phages are transmitted during FMT. Phages are a major vehicle for horizontal gene transfer in the human gut and thereby largely influence bacterial evolution, diversity and metabolism. Thus, the transfer of undesired phage-encoded genes, such as those conferring antibiotic resistance or bacterial virulence may be a consequence of FMT-transmitted phages and should be avoided by better understanding of the virome. The composition of phage populations may be more complex than just reflecting bacterial communities and therefore by themselves contribute to inflammatory diseases such as IBD and obesity in humans and mice, respectively. Conversely, transmitted phages may also exert beneficial functions, such as replenishing the recently described non-host-derived mucosal immunity to bacterial pathogens. These data suggest that, similar to bacterial microbiota, the virome can be pathologically altered in patients, and its return to a “healthy” state by FMT may result in clinical improvement. Screening FMT donors for “healthy” viromes, in addition to bacterial microbiota, may therefore become an important aim of clinical metagenomics. In summary we showed, to our surprise, that phages assume highly donor-similar characteristics following FMT with little change over time, despite contemporaneous bacterial dysbiosis. Bacterial communities attained donor similarity only later and then remained stable for at least 4.5 y post-FMT. Thus, stable core phage populations may be an early indicator of the properties of the enteric community transferred during FMT. We speculate that the phage stability may be due to transmission of a core population within the gut virome, in analogy to population dynamics in the ocean. The core population is defined by a distinct composition of phage protein domains and presumably predominates a flexible virome. Variations derived from this core may have been too low in abundance to be detectable here. Further studies are required to better understand these results and compare donor and recipient viromes for a putative predictive value for the clinical success of FMT in rCDI and, more generally, in the increasing number of diseases associated with viral dysbiosis, including IBD and obesity.
  33 in total

Review 1.  The global virome: not as big as we thought?

Authors:  J Cesar Ignacio-Espinoza; Sergei A Solonenko; Matthew B Sullivan
Journal:  Curr Opin Virol       Date:  2013-07-26       Impact factor: 7.090

2.  Rapid evolution of the human gut virome.

Authors:  Samuel Minot; Alexandra Bryson; Christel Chehoud; Gary D Wu; James D Lewis; Frederic D Bushman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

3.  Increased fecal viral content associated with obesity in mice.

Authors:  Hariom Yadav; Shalini Jain; Ravinder Nagpal; Francesco Marotta
Journal:  World J Diabetes       Date:  2016-08-10

4.  Disease-specific alterations in the enteric virome in inflammatory bowel disease.

Authors:  Jason M Norman; Scott A Handley; Megan T Baldridge; Lindsay Droit; Catherine Y Liu; Brian C Keller; Amal Kambal; Cynthia L Monaco; Guoyan Zhao; Phillip Fleshner; Thaddeus S Stappenbeck; Dermot P B McGovern; Ali Keshavarzian; Ece A Mutlu; Jenny Sauk; Dirk Gevers; Ramnik J Xavier; David Wang; Miles Parkes; Herbert W Virgin
Journal:  Cell       Date:  2015-01-22       Impact factor: 41.582

Review 5.  Exploiting gut bacteriophages for human health.

Authors:  Marion Dalmasso; Colin Hill; R Paul Ross
Journal:  Trends Microbiol       Date:  2014-03-20       Impact factor: 17.079

6.  Bacteriophage adhering to mucus provide a non-host-derived immunity.

Authors:  Jeremy J Barr; Rita Auro; Mike Furlan; Katrine L Whiteson; Marcella L Erb; Joe Pogliano; Aleksandr Stotland; Roland Wolkowicz; Andrew S Cutting; Kelly S Doran; Peter Salamon; Merry Youle; Forest Rohwer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

7.  GenBank.

Authors:  Dennis A Benson; Karen Clark; Ilene Karsch-Mizrachi; David J Lipman; James Ostell; Eric W Sayers
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 19.160

8.  A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes.

Authors:  Bas E Dutilh; Noriko Cassman; Katelyn McNair; Savannah E Sanchez; Genivaldo G Z Silva; Lance Boling; Jeremy J Barr; Daan R Speth; Victor Seguritan; Ramy K Aziz; Ben Felts; Elizabeth A Dinsdale; John L Mokili; Robert A Edwards
Journal:  Nat Commun       Date:  2014-07-24       Impact factor: 14.919

9.  The Pfam protein families database: towards a more sustainable future.

Authors:  Robert D Finn; Penelope Coggill; Ruth Y Eberhardt; Sean R Eddy; Jaina Mistry; Alex L Mitchell; Simon C Potter; Marco Punta; Matloob Qureshi; Amaia Sangrador-Vegas; Gustavo A Salazar; John Tate; Alex Bateman
Journal:  Nucleic Acids Res       Date:  2015-12-15       Impact factor: 16.971

Review 10.  The human gut microbiota and virome: Potential therapeutic implications.

Authors:  Emidio Scarpellini; Gianluca Ianiro; Fabia Attili; Chiara Bassanelli; Adriano De Santis; Antonio Gasbarrini
Journal:  Dig Liver Dis       Date:  2015-07-18       Impact factor: 4.088

View more
  31 in total

1.  The need to move away from fecal transplant towards targeted, refined microbiome therapy.

Authors:  Lindsey Russell; Tanya Monaghan; Dina Kao
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  Fecal microbiota transplantation-early steps on a long journey ahead.

Authors:  Alexander Khoruts
Journal:  Gut Microbes       Date:  2017-04-10

Review 3.  Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Marie-Céline Zanella; Samuel Cordey; Laurent Kaiser
Journal:  Clin Microbiol Rev       Date:  2020-08-26       Impact factor: 26.132

Review 4.  Phages of life - the path to pharma.

Authors:  Amanda Forde; Colin Hill
Journal:  Br J Pharmacol       Date:  2018-01-03       Impact factor: 8.739

Review 5.  The Human Virome: Implications for Clinical Practice in Transplantation Medicine.

Authors:  Susanna K Tan; David A Relman; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2017-07-19       Impact factor: 5.948

Review 6.  Phages and their potential to modulate the microbiome and immunity.

Authors:  Sara Federici; Samuel P Nobs; Eran Elinav
Journal:  Cell Mol Immunol       Date:  2020-09-08       Impact factor: 11.530

7.  Bacteriophages in the gastrointestinal tract and their implications.

Authors:  Marzanna Łusiak-Szelachowska; Beata Weber-Dąbrowska; Ewa Jończyk-Matysiak; Renata Wojciechowska; Andrzej Górski
Journal:  Gut Pathog       Date:  2017-08-10       Impact factor: 4.181

8.  Commentary: Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome.

Authors:  Blessing O Anonye
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

9.  Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome.

Authors:  Tao Zuo; Sunny H Wong; Kelvin Lam; Rashid Lui; Kitty Cheung; Whitney Tang; Jessica Y L Ching; Paul K S Chan; Martin C W Chan; Justin C Y Wu; Francis K L Chan; Jun Yu; Joseph J Y Sung; Siew C Ng
Journal:  Gut       Date:  2017-05-24       Impact factor: 23.059

Review 10.  Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections.

Authors:  Amoe Baktash; Elisabeth M Terveer; Romy D Zwittink; Bastian V H Hornung; Jeroen Corver; Ed J Kuijper; Wiep Klaas Smits
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.